Robuta

https://pmc.ncbi.nlm.nih.gov/articles/PMC6738625/ Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who... Irritable bowel syndrome with diarrhea (IBS-D) is a functional gastrointestinal disorder with limited effective treatment options. We evaluated the efficacy... efficacy and safety https://pmc.ncbi.nlm.nih.gov/articles/PMC5244598/ Eluxadoline: a promising therapy that raises many questions - PMC many questions eluxadoline promising therapy raises https://www.nice.org.uk/guidance/ta471 Eluxadoline for treating irritable bowel syndrome with diarrhoea | Guidance | NICE We have withdrawn this guidance. Allergan has stopped marketing eluxadoline (Truberzi) for commercial reasons and its marketing authorisation has been withdrawn irritable bowel syndrome eluxadoline treating diarrhoea guidance https://pmc.ncbi.nlm.nih.gov/articles/PMC5481293/ Eluxadoline (Viberzi): A Mu-Opioid Receptor Agonist for the Treatment Of Irritable Bowel Syndrome... Eluxadoline (Viberzi) for the treatment of irritable bowel syndrome with diarrhea https://www.viberzi.com/ VIBERZI (eluxadoline) CIV | Official Site Learn about VIBERZI (eluxadoline) a treatment option for adult patients suffering from irritable bowel syndrome with diarrhea. viberzi eluxadoline civ official site